National Vision Holdings, Inc. (EYE) stock
EYENasdaqOphthalmic GoodsFiscal year ends January 2
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3040% below fair value
$18.57+0.48 (+2.65%)
Close on Nov 12, 2026Market cap $1.47BP/E 22.9Yield –
National Vision EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
National Vision's EPS for the twelve months ending Oct 3, 2026 was $0.81. For fiscal 2025 it was $0.37. Over ten years it grew 20.0% a year on average. The highest annual figure on record is $1.43 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $0.37 | – |
| FY2024 | Dec 28, 2024 | -$0.36 | – |
| FY2023 | Dec 30, 2023 | -$0.84 | -261.5% |
| FY2022 | Dec 31, 2022 | $0.52 | -63.6% |
| FY2021 | Jan 1, 2022 | $1.43 | +225.0% |
| FY2020 | Jan 2, 2021 | $0.44 | +10.0% |
| FY2019 | Dec 28, 2019 | $0.40 | +33.3% |
| FY2018 | Dec 29, 2018 | $0.30 | -57.1% |
| FY2017 | Dec 30, 2017 | $0.70 | +204.3% |
| FY2016 | Dec 31, 2016 | $0.23 | +283.3% |
| FY2015 | Jan 2, 2016 | $0.06 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | $0.24 | +500.0% |
| Q2 FY2026 | Jul 4, 2026 | $0.15 | +36.4% |
| Q1 FY2026 | Apr 4, 2026 | $0.38 | +111.1% |
| Q4 FY2025 | Jan 3, 2026 | $0.04 | – |
| Q3 FY2025 | Sep 27, 2025 | $0.04 | – |
| Q2 FY2025 | Jun 28, 2025 | $0.11 | – |
| Q1 FY2025 | Mar 29, 2025 | $0.18 | +20.0% |
| Q4 FY2024 | Dec 28, 2024 | -$0.36 | – |
| Q3 FY2024 | Sep 28, 2024 | -$0.11 | – |
| Q2 FY2024 | Jun 29, 2024 | -$0.04 | -157.1% |
| Q1 FY2024 | Mar 30, 2024 | $0.15 | -25.0% |
| Q4 FY2023 | Dec 30, 2023 | -$0.20 | -233.3% |
| Q3 FY2023 | Sep 30, 2023 | -$0.94 | -883.3% |
| Q2 FY2023 | Jul 1, 2023 | $0.07 | -79.4% |
| Q1 FY2023 | Apr 1, 2023 | $0.20 | +122.2% |
| Q3 FY2022 | Oct 1, 2022 | $0.15 | -66.7% |
| Q2 FY2022 | Jul 2, 2022 | $0.12 | -71.4% |
| Q1 FY2022 | Apr 2, 2022 | $0.34 | -29.2% |
| Q4 FY2021 | Jan 1, 2022 | $0.09 | -78.6% |
| Q3 FY2021 | Oct 2, 2021 | $0.45 | +7.1% |
| Q2 FY2021 | Jul 3, 2021 | $0.42 | – |
| Q1 FY2021 | Apr 3, 2021 | $0.48 | +300.0% |
| Q4 FY2020 | Jan 2, 2021 | $0.42 | +740.0% |
| Q3 FY2020 | Sep 26, 2020 | $0.42 | +4100.0% |
| Q2 FY2020 | Jun 27, 2020 | -$0.55 | -523.1% |
| Q1 FY2020 | Mar 28, 2020 | $0.12 | -42.9% |
| Q4 FY2019 | Dec 28, 2019 | $0.05 | – |
| Q3 FY2019 | Sep 28, 2019 | $0.01 | -83.3% |
| Q2 FY2019 | Jun 29, 2019 | $0.13 | -18.8% |
| Q1 FY2019 | Mar 30, 2019 | $0.21 | -32.3% |
| Q4 FY2018 | Dec 29, 2018 | -$0.24 | -164.9% |
| Q3 FY2018 | Sep 29, 2018 | $0.06 | +200.0% |
| Q2 FY2018 | Jun 30, 2018 | $0.16 | – |
| Q1 FY2018 | Mar 31, 2018 | $0.31 | +6.9% |
| Q4 FY2017 | Dec 30, 2017 | $0.37 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.02 | – |
| Q2 FY2017 | Jul 1, 2017 | -$0.03 | – |
| Q1 FY2017 | Apr 1, 2017 | $0.29 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.17 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?